Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Outer membrane protein P2 (OMP P2) is the most abundant surface protein in Haemophilus influenzae, functioning as a non-specific porin that facilitates the passive diffusion of nutrients and small molecules across the bacterial outer membrane [1, 2]. It plays a critical role in the pathogen's interaction with the host, acting as an adhesin that binds to the laminin receptor (LamR) on human brain microvascular endothelial cells, which is a key step in crossing the blood-brain barrier during meningitis [19]. OMP P2 is a primary target for the human bactericidal antibody response and has been extensively investigated as a vaccine candidate for both encapsulated (type b) and nontypeable H. influenzae (NTHi) [12, 17]. However, the protein exhibits significant antigenic heterogeneity, particularly in its surface-exposed loops, which allows the bacteria to evade the host immune system and complicates vaccine design [4, 5]. Additionally, OMP P2 is clinically important in the context of antibiotic resistance, as mutations that alter porin permeability can reduce the entry of beta-lactam antibiotics, such as imipenem, into the cell [3, 15]. Understanding the structural and functional variations of OMP P2 is therefore essential for developing effective therapeutics and preventative measures against H. influenzae infections [18].
Acts as a porin channel for the passive diffusion of antibiotics into the bacterium and serves as an antigenic target for the induction of bactericidal antibodies.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Outer membrane protein P2 (OMP P2) (OMP P2).